Open Access BASE2016

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

Calderon, M. A; Demoly, Pascal; Casale, T; Akdis, C. A; Bachert, Claus; Bewick, M; Bilò, B. M; Bohle, Barbara; Bonini, S; Bush, A; Caimmi, Davide Paolo; Canonica, G. W; Cardona, V; Chiriac, A. M; Cox, L; Custovic, A; Blay, Frederic De; Devillier, P; Didier, A; Lorenzo, G. Di; Toit, G. Du; Durham, S. R; Eng, P; Fiocchi, A; Fox, A. T; Gerth van Wijk, R; Gomez, R. M; Haathela, T; Halken, S; Hellings, P. W; Jacobsen, L; Just, Jocelyne; Tanno, L. K; Kleine‑Tebbe, J; Klimek, Ludger; Knol, E. F; Kuna, P; Larenas‑Linnemann, D. E; Linneberg, Allan; Matricardi, M; Malling, H. J; Moesges, R; Mullol i Miret, Joaquim; Muraro, A; Papadopoulos, N. G; Passalacqua, Giovanni; Pastorello, E; Pfaar, Oliver; Price, David B; Rodriguez del Rio, P; Ruëff, R; Samolinski, B; Scadding, Glenis; Senti, G; Shamji, M. H; Sheikh, A; Sisul, J. C; Sole, D; Sturm, G. J; Tabar, A; Van Ree, R; Ventura, M. T; Vidal Lancis, Maria Carmen; Varga, E. M; Worm, M; Zuberbier, T; Bousquet, J

Order using Access(Open Access)

Abstract

Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.

Subjects

Al·lèrgiaImmunoteràpiaAllergyImmunotherapy

Languages

English

Publisher

BioMed Central

ExportReport Issue

Report Issue

If you have problems with the access to a found title, you can use this form to contact us. You can also use this form to write to us if you have noticed any errors in the title display.